7Baggers
Quarterly
Annual
    Unit: USD2025-08-01 2025-05-02 2025-01-31 2024-11-01 2024-08-02 2024-05-03 2024-02-02 2023-11-03 2023-08-04 2023-05-05 2023-02-03 2022-10-28 2022-07-29 2022-04-29 2022-01-28 2021-10-29 2021-07-30 2021-04-30 2021-01-29 2020-10-30 2020-07-31 2020-05-01 2020-01-31 2019-11-01 2019-08-02 2019-05-03 2019-02-01 2018-11-02 2018-08-03 2018-05-05 2018-05-04 2018-02-02 2017-11-03 2016-05-06 2016-01-29 2015-10-30 2015-07-31 2015-05-01 2015-01-30 2014-10-31 2014-08-01 2014-05-02 
      
    		                                          
      cash flows from operating activities:
    		                                          
      net income
    		127,000,000 68,000,000 98,000,000 106,000,000 81,000,000 77,000,000 39,000,000 93,000,000 247,000,000 98,000,000 75,000,000 80,000,000 74,000,000 74,000,000 44,000,000 71,000,000 82,000,000 82,000,000 61,000,000 60,000,000 53,000,000 37,000,000 60,000,000 56,000,000 57,000,000 56,000,000 -9,000,000 61,000,000 49,000,000 49,000,000 49,000,000 67,000,000 58,000,000 33,000,000 28,000,000 34,000,000 22,000,000 33,000,000 36,000,000 37,000,000 34,000,000 34,000,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                          
      depreciation and amortization
    		35,000,000 36,000,000 36,000,000 35,000,000 34,000,000 35,000,000 36,000,000 34,000,000 36,000,000 36,000,000 39,000,000 37,000,000 40,000,000 41,000,000 42,000,000 44,000,000 37,000,000 42,000,000 48,000,000 48,000,000 50,000,000 33,000,000 35,000,000 33,000,000 34,000,000 36,000,000 16,000,000 11,000,000 12,000,000 10,000,000 11,000,000 5,000,000 5,000,000 16,000,000 20,000,000 18,000,000 19,000,000 5,000,000 5,000,000 6,000,000 5,000,000 5,000,000 
      stock-based compensation expense
    		10,000,000 15,000,000 15,000,000 13,000,000 12,000,000 13,000,000 26,000,000 15,000,000 15,000,000 12,000,000 13,000,000 12,000,000 12,000,000 11,000,000 11,000,000 11,000,000 14,000,000 10,000,000 12,000,000 11,000,000 10,000,000 9,000,000 8,000,000 9,000,000 12,000,000 8,000,000 21,000,000 9,000,000 8,000,000 8,000,000 8,000,000 2,000,000 3,000,000 10,000,000 8,000,000 8,000,000 8,000,000 9,000,000 9,000,000 8,000,000 9,000,000 9,000,000 
      deferred income taxes
    		  12,000,000 -7,000,000   16,000,000 -8,000,000 -19,000,000 -6,000,000 12,000,000 -7,000,000 -24,000,000 2,000,000 18,000,000 10,000,000 11,000,000 20,000,000 -5,000,000 6,000,000 1,000,000 10,000,000 17,000,000 11,000,000 7,000,000 9,000,000               0 1,000,000 
      other
    		  -3,000,000 -1,000,000 -2,000,000 -1,000,000 2,000,000 -7,000,000 0 -3,000,000 -5,000,000 0   -1,000,000 -3,000,000 -1,000,000 -1,000,000 -1,000,000 0       0                
      increase resulting from changes in operating assets and liabilities:
    		                                          
      receivables
    		58,000,000 -9,000,000 22,000,000 -76,000,000 -12,000,000 -20,000,000 96,000,000 -52,000,000 37,000,000 -127,000,000 123,000,000 -23,000,000 68,000,000 -89,000,000 92,000,000 -43,000,000 -19,000,000 -61,000,000 90,000,000 -20,000,000 8,000,000 143,000,000   6,000,000 11,000,000    -43,000,000 8,000,000   -61,000,000 39,000,000 -8,000,000 -19,000,000 -17,000,000 85,000,000 10,000,000 -35,000,000 17,000,000 
      prepaid expenses and other current assets
    		-113,000,000 6,000,000 -7,000,000 17,000,000 -1,000,000 15,000,000                                     
      accounts payable and other accrued liabilities
    		                                          
      accrued payroll and employee benefits
    		48,000,000 -51,000,000 28,000,000 -27,000,000 51,000,000 -83,000,000 53,000,000 -13,000,000 52,000,000 -43,000,000 -68,000,000 59,000,000 -58,000,000 31,000,000 -35,000,000 25,000,000 -37,000,000 57,000,000 -46,000,000 61,000,000 -3,000,000 83,000,000 -75,000,000 60,000,000 0 18,000,000 -47,000,000 71,000,000 -9,000,000 22,000,000 34,000,000  49,000,000 17,000,000 11,000,000 -16,000,000 30,000,000 -29,000,000 7,000,000 -8,000,000 30,000,000 -25,000,000 
      operating lease assets and liabilities
    		-2,000,000 -2,000,000 1,000,000 -2,000,000 -2,000,000 -3,000,000 -1,000,000 -1,000,000 1,000,000 -3,000,000 -2,000,000   -4,000,000 1,000,000 1,000,000 -2,000,000 5,000,000 2,000,000 -2,000,000                       
      other assets and other long-term liabilities
    		-33,000,000 4,000,000                                         
      net cash from operating activities
    		122,000,000 100,000,000 115,000,000 143,000,000 138,000,000 98,000,000 63,000,000 101,000,000 150,000,000 82,000,000 145,000,000 128,000,000 141,000,000 118,000,000 103,000,000 134,000,000 92,000,000 189,000,000 53,000,000 231,000,000 104,000,000 367,000,000 69,000,000 116,000,000 95,000,000 178,000,000 22,000,000 109,000,000 -12,000,000 88,000,000 88,000,000            
      capex
    		-7,000,000 -8,000,000 -15,000,000 -9,000,000 -6,000,000 -6,000,000 -11,000,000 -4,000,000 -6,000,000 -6,000,000 -7,000,000 -6,000,000 -7,000,000 -5,000,000 -9,000,000 -10,000,000 -7,000,000 -10,000,000 -14,000,000 -9,000,000 0 0 0 0 0 0 0 0 0 -4,000,000 0            
      free cash flows
    		115,000,000 92,000,000 100,000,000 134,000,000 132,000,000 92,000,000 52,000,000 97,000,000 144,000,000 76,000,000 138,000,000 122,000,000 134,000,000 113,000,000 94,000,000 124,000,000 85,000,000 179,000,000 39,000,000 222,000,000 104,000,000 367,000,000 69,000,000 116,000,000 95,000,000 178,000,000 22,000,000 109,000,000 -12,000,000 84,000,000 88,000,000            
      cash flows from investing activities:
    		                                          
      expenditures for property, plant, and equipment
    		-7,000,000 -8,000,000 -15,000,000 -9,000,000 -6,000,000 -6,000,000 -11,000,000 -4,000,000 -6,000,000 -6,000,000 -7,000,000 -6,000,000 -7,000,000 -5,000,000 -9,000,000 -10,000,000 -7,000,000 -10,000,000 -14,000,000 -9,000,000          -4,000,000    -4,000,000         
      purchases of marketable securities
    		0 -4,000,000 -3,000,000 -3,000,000 -4,000,000 -4,000,000 -2,000,000 -1,000,000 -2,000,000 -3,000,000 -2,000,000 -1,000,000 -2,000,000 -2,000,000 -4,000,000 -2,000,000 -1,000,000 -2,000,000 -1,000,000 -1,000,000                       
      sales of marketable securities
    		1,000,000 3,000,000 2,000,000 4,000,000 2,000,000 4,000,000 1,000,000 1,000,000 3,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 2,000,000 2,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 6,000,000 1,000,000 0                   
      contributions to investments
    		-1,000,000 -6,000,000                                         
      net cash from investing activities
    		-7,000,000 -15,000,000 -20,000,000 1,000,000 -9,000,000 -7,000,000 -10,000,000 -10,000,000 -2,000,000 336,000,000 -13,000,000 -6,000,000 -11,000,000 -6,000,000 -20,000,000 -16,000,000 -252,000,000 -4,000,000 -2,000,000 -6,000,000          -4,000,000             
      cash flows from financing activities:
    		                                          
      proceeds from borrowings
    		557,000,000 750,000,000 385,000,000 441,000,000 380,000,000 293,000,000 0 0 0 160,000,000 210,000,000 115,000,000   0 0 100,000,000 16,000,000 0 0 0 1,000,000,000 0 0   1,068,000,000 766,000,000    -184,000,000   0 0       
      principal payments on borrowings
    		-546,000,000 -689,000,000 -325,000,000 -450,000,000 -296,000,000 -310,000,000 -166,000,000 -15,000,000 -100,000,000 -160,000,000 -210,000,000 -205,000,000 -516,000,000 -59,000,000 -35,000,000 -23,000,000 -22,000,000 -39,000,000 -23,000,000 -218,000,000          -9,000,000    -15,000,000 -43,000,000 -13,000,000 -9,000,000 -7,000,000 -6,000,000    
      stock repurchased and retired or withheld for taxes on equity awards
    		-110,000,000 -142,000,000 -133,000,000 -121,000,000 -201,000,000 -103,000,000 -89,000,000 -103,000,000 -102,000,000 -88,000,000 -59,000,000 -60,000,000 -64,000,000 -84,000,000 -72,000,000 -63,000,000 -38,000,000 -53,000,000 -21,000,000 -1,000,000          -65,000,000    -47,000,000 -33,000,000 -18,000,000 -1,000,000 -17,000,000 -26,000,000 -51,000,000   
      dividend payments to stockholders
    		-17,000,000 -19,000,000 -18,000,000 -18,000,000 -19,000,000 -20,000,000 -19,000,000 -19,000,000 -20,000,000 -21,000,000 -20,000,000 -21,000,000 -20,000,000 -22,000,000 -21,000,000 -21,000,000 -22,000,000 -22,000,000 -22,000,000 -21,000,000          -14,000,000    -14,000,000 -14,000,000 -13,000,000 -15,000,000 -13,000,000 -12,000,000 -13,000,000 -14,000,000 -13,000,000 
      issuances of stock
    		6,000,000 6,000,000 6,000,000 5,000,000 5,000,000 4,000,000 4,000,000 5,000,000 4,000,000 4,000,000 4,000,000 4,000,000 4,000,000 4,000,000 4,000,000 4,000,000 4,000,000 4,000,000 4,000,000 3,000,000 3,000,000 3,000,000 3,000,000 2,000,000 3,000,000 2,000,000 2,000,000 2,000,000 1,000,000 2,000,000 2,000,000 3,000,000 2,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 0 1,000,000 
      net cash from financing activities
    		-114,000,000 -94,000,000 -85,000,000 -146,000,000 -131,000,000 -136,000,000 -270,000,000 -132,000,000 -218,000,000 -105,000,000 -76,000,000 -168,000,000 -87,000,000 -162,000,000 -125,000,000 -103,000,000 22,000,000 -95,000,000 -62,000,000 -239,000,000 -162,000,000 927,000,000        -88,000,000             
      net decrease in cash, cash equivalents and restricted cash
    		1,000,000 -9,000,000          -46,000,000   -42,000,000               -4,000,000             
      cash, cash equivalents and restricted cash at beginning of period
    		0 64,000,000 0 0 0 103,000,000 0 0 0 118,000,000 0 0 0 115,000,000 0 0 0 190,000,000 0 0 0 202,000,000 0 0 0 246,000,000 0 -66,000,000 -66,000,000 218,000,000 152,000,000            
      cash, cash equivalents and restricted cash at end of period
    		1,000,000 55,000,000 10,000,000 -2,000,000 -2,000,000 58,000,000 -217,000,000 -41,000,000 -70,000,000 431,000,000 56,000,000 -46,000,000 43,000,000 65,000,000 -42,000,000 15,000,000 -138,000,000 280,000,000 -11,000,000 -14,000,000 -79,000,000 294,000,000 26,000,000 -12,000,000 28,000,000 160,000,000 44,000,000 54,000,000 -100,000,000 214,000,000 160,000,000            
      science applications international corporation
    		                                          
      notes to condensed consolidated financial statements
    		                                          
      accounts payable and accrued liabilities
    		 33,000,000 -73,000,000 80,000,000 -19,000,000 60,000,000 -107,000,000 68,000,000 -61,000,000 113,000,000 12,000,000 -50,000,000 -10,000,000 39,000,000 -17,000,000 5,000,000 -2,000,000 44,000,000 -85,000,000 13,000,000 -70,000,000 66,000,000 -16,000,000 57,000,000 1,000,000 20,000,000    16,000,000  62,000,000 67,000,000 10,000,000 8,000,000 38,000,000 -13,000,000 11,000,000 -26,000,000 18,000,000 13,000,000 -24,000,000 
      gain on divestitures
    		      0 0          -3,000,000                         
      increase resulting from changes in operating assets and liabilities, net of the effect of the acquisitions and divestitures:
    		                                          
      other assets
    		  -9,000,000 11,000,000   -19,000,000 8,000,000 -7,000,000 4,000,000 1,000,000 0 2,000,000 3,000,000 5,000,000 0 -4,000,000 -4,000,000 -3,000,000 -4,000,000    16,000,000 16,000,000 11,000,000    1,000,000  3,000,000 2,000,000   0 0 1,000,000    1,000,000 
      other long-term liabilities
    		  -12,000,000 -1,000,000 7,000,000 5,000,000 3,000,000 6,000,000 13,000,000 2,000,000 13,000,000   -1,000,000 -50,000,000 3,000,000 4,000,000 -3,000,000 -20,000,000 31,000,000 48,000,000 5,000,000     -7,000,000 5,000,000 1,000,000 2,000,000 1,000,000 2,000,000   -2,000,000 -3,000,000 -1,000,000 2,000,000 -1,000,000 1,000,000   
      proceeds from sale of equity method investments
    		  0                                        
      proceeds from divestitures
    		      0 1,000,000       0 0 0 8,000,000                         
      cash divested upon deconsolidation of joint venture
    		      0 0 0 -8,000,000                                 
      debt issuance costs
    		          0 -1,000,000       0 0                       
      net increase in cash, cash equivalents and restricted cash
    		  10,000,000 -2,000,000 -2,000,000 -45,000,000 -217,000,000 -41,000,000 -70,000,000 313,000,000    -50,000,000   -138,000,000 90,000,000   -79,000,000 92,000,000     44,000,000    8,000,000            
      see accompanying notes to consolidated financial statements.
    		                                          
      supplementary cash flow disclosure:
    		                                          
      cash paid for interest
    		                                          
      cash paid for income taxes
    		                                          
      non-cash investing activities:
    		                                          
      increase in accrued property, plant, and equipment
    		                                          
      non-cash financing activities:
    		                                          
      increase in accrued plan share repurchases
    		                                          
      increase in accrued excise taxes on plan share repurchases
    		                                          
      science applications international corporationnotes to the consolidated financial statements
    		                                          
      gain on sale of equity method investments and long-lived assets
    		                                          
      increase resulting from changes in operating assets and liabilities, net of the effect of divestitures:
    		                                          
      income taxes payable
    		   0    -53,000,000    23,000,000                      16,000,000    14,000,000     
      proceeds from sale of long-lived assets
    		       0                                   
      excise tax payments on stock repurchases
    		                                          
      (gain) loss on sale of long-lived assets
    		                                          
      (gain) loss on divestitures
    		              0 0                           
      proceeds from assets held for sale
    		         355,000,000                                 
      amortization of off-market customer contracts
    		      0 -1,000,000 -2,000,000 -2,000,000 -2,000,000 -6,000,000 -4,000,000 -2,000,000 -3,000,000 -13,000,000 -13,000,000 -4,000,000 -4,000,000 -4,000,000                       
      amortization of debt issuance costs
    		      3,000,000 0 3,000,000 1,000,000 1,000,000 2,000,000 4,000,000 2,000,000 1,000,000 2,000,000 2,000,000 2,000,000 2,000,000 7,000,000 6,000,000 6,000,000                     
      impairment of assets
    		                                          
      inventory, prepaid expenses, and other current assets
    		                                          
      cash paid for acquisitions, net of cash acquired
    		              -8,000,000 -3,000,000                           
      distributions to non-controlling interest
    		          -1,000,000 0 -1,000,000 -1,000,000 -1,000,000 0                           
      non-cash investing and financing activities:
    		                                          
      decrease in accrued property, plant, and equipment
    		                                          
      gain on sale of long-lived assets
    		       0                                   
      inventory, prepaid expenses and other current assets
    		       5,000,000 4,000,000 4,000,000  0 -4,000,000 11,000,000  18,000,000 15,000,000 -5,000,000  24,000,000     -5,000,000 16,000,000   -17,000,000 23,000,000 7,000,000 32,000,000 36,000,000 -2,000,000 -6,000,000 -2,000,000 -6,000,000 3,000,000 -16,000,000 5,000,000 10,000,000 17,000,000 
      notes to condensed and consolidated financial statements
    		                                          
      gain on divestiture
    		         -7,000,000                                 
      increase resulting from changes in operating assets and liabilities, net of the effect of the acquisitions:
    		                                          
      increase resulting from changes in operating assets and liabilities, net of the effect of acquisitions:
    		                                          
      impairment of right of use assets
    		               0 3,000,000 7,000,000                         
      increase resulting from changes in operating assets and liabilities, net of the effect of the acquisition:
    		                                          
      cash paid for acquisition
    		                   0                       
      (distributions to) contributions from non-controlling interest
    		                 -1,000,000                         
      loss on divestiture
    		                  0 0                       
      loss on extinguishment of debt
    		                          0                
      provisions for inventory and deferred contract costs
    		                                          
      proceeds from divestiture
    		                  13,000,000 3,000,000                       
      equity issuance costs
    		                                          
      increase in accrued plant, property, and equipment
    		                                          
      fair value of equity consideration paid for acquisition
    		                                          
      contributions from (distributions to) non-controlling interest
    		                     2,000,000                     
      cash paid for acquisition, net of cash acquired
    		                                  0 0       
      disbursements for obligations assumed from scitor acquisition
    		                             -2,000,000    -2,000,000 -2,000,000 -1,000,000       
      decrease in accrued plan share repurchases
    		                                          
      benefit from inventory
    		                                          
      excess tax benefits from stock-based compensation
    		                                 -4,000,000 -1,000,000 -1,000,000 -5,000,000 -3,000,000 -1,000,000 0 -1,000,000 -1,000,000 
      loss on disposal of property, plant, and equipment
    		                                          
      contributions from non-controlling interest
    		                                          
      first quarter
    		                             13,000,000             
      second quarter
    		                             13,000,000             
      third quarter
    		                             13,000,000             
      fourth quarter
    		                             13,000,000             
      fiscal year
    		                             52,000,000             
      deferred financing costs
    		                                  0 0 -16,000,000 -1,000,000     
      increase resulting from changes in operating assets and liabilities net of the effect of the acquisition:
    		                                          
      asset acquisition
    		                                          
      increase in accrued cash dividend equivalents
    		                                          
      science applications international corporationnotes to consolidated financial statements
    		                                          
      total cash flows from operating activities
    		                                 35,000,000 108,000,000 68,000,000 21,000,000 29,000,000 96,000,000 82,000,000 65,000,000 34,000,000 
      change in restricted cash
    		                                 1,000,000 2,000,000 1,000,000       
      total cash flows used in investing activities
    		                                 -3,000,000 -7,000,000 -4,000,000 -786,000,000 -1,000,000 -7,000,000 -5,000,000 -3,000,000 -7,000,000 
      total cash flows from financing activities
    		                                  -90,000,000 -43,000,000   -42,000,000   -44,000,000 
      total increase in cash and cash equivalents
    		                                          
      cash and cash equivalents at beginning of period
    		                                 195,000,000 0 0 0 301,000,000 0 0 0 254,000,000 
      cash and cash equivalents at end of period
    		                                 154,000,000 11,000,000 21,000,000 -132,000,000 295,000,000 47,000,000 7,000,000 10,000,000 237,000,000 
      total decrease in cash and cash equivalents
    		                                 -41,000,000  21,000,000 -132,000,000 -6,000,000    -17,000,000 
      decrease in accrued plant, property, and equipment
    		                                          
      total cash flows used in financing activities
    		                                 -73,000,000    -34,000,000     
      basic weighted-average number of shares outstanding
    		                                 45,000,000  0 200,000 45,800,000  -1,000,000   
      dilutive common share equivalents - stock options and other stock-based awards
    		                                 1,500,000  -200,000 -200,000 1,800,000     
      diluted weighted-average number of shares outstanding
    		                                 46,500,000  -200,000 0 47,600,000  -700,000   
      loss on disposal of property, plant and equipment
    		                                          
      expenditures for property, plant and equipment
    		                                  -9,000,000 -5,000,000 -5,000,000 -1,000,000 -7,000,000 -5,000,000 -3,000,000 -7,000,000 
      dividend paid to former parent
    		                                          
      net transfers to former parent
    		                                          
      capital contribution from former parent
    		                                          
      net transfers of property, plant, and equipment from former parent
    		                                          
      increase in accrued stock repurchases
    		                                          
      favorable adjustments
    		                                          
      unfavorable adjustments
    		                                          
      net favorable (unfavorable) adjustments
    		                                          
      income tax effect
    		                                          
      net favorable (unfavorable) adjustments, after tax
    		                                          
      basic eps impact
    		                                          
      diluted eps impact
    		                                          
      increase resulting from changes in operating assets and liabilities
    		                                          
      net of the effect of the acquisition:
    		                                          
      increase in cash resulting from changes in:
    		                                          
      proceeds from sale of assets
    		                                          
      proceeds from borrowings under term loan facility
    		                                          
      net transfers of property, plant, and equipment from (to) former parent
    		                                          
      landlord provided tenant improvements
    		                                          
      net transfers of property, plant and equipment from former parent
    		                                          
      dilutive common share equivalents—stock options and other stock-based awards
    		                                          
      stock repurchased and retired or withheld for taxes on vested restricted stock
    		                                         -33,000,000 
      net transfers from former parent
    		                                          
      adjustments to reconcile net income to net cash from operations:
    		                                          
      stock-based compensation
    		                                          
      net gain on sales and disposals of assets
    		                                          
      borrowing under term loan facility
    		                                          
      payment of debt issuance costs
    		                                          
      contribution from former parent
    		                                          
      dividend payments to common stockholders
    		                                          
      issuances of common stock
    		                                          
      repurchases of common stock
    		                                          
      payments on capital leases and notes payable
    		                                          
      supplementary cash flow disclosure
    		                                          
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.